
Histacort®
Potent Synergistic Anti-allergic Dual Mechanism of Action Association





Each mL contains: Prednisolone (as acetate) 10 mg Chlorpheniramine maleate 4 mg Excipients q.s.ad. 1 mL.
Symptomatic treatment of pathologies associated with histamine release and as a corticosteroid anti-inflammatory whenever an antihistamine effect is required. Allergic reactions in general, anaphylaxis2, drug and food reactions, stings, urticaria. Allergic dermatoses/dermatitis, atopic dermatitis, contact dermatitis, summer and sting dermatitis, pruritus3 (regardless of cause) and allergic inflammation associated with allergic, parasitic, pustular and non-specific dermatitis and otitis. Respiratory allergies, allergic rhinitis, pollinosis, ocular allergies, inflammatory ophthalmic disorders4 when systemic corticotherapy is indicated, allergic bronchitis (asthma), shock states. Allergic purpura, recurrent airway obstruction and neonatal isoerythrolysis in equines. Tracheobronchitis, bronchitis, including all allergic bronchitis. Bronchospasm, ketosis, coadjuvant in the treatment of arthritic and rheumatic diseases, arthropathies and anemias (and other autoimmune diseases), bursitis among others; whenever a corticoid effect associated to the antihistamine is required.
SENASA Registry: F.081.042.I.00022